Baltimore-Washington Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Baltimore-Washington Financial Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,155	Closed	-$241K	–	145
2023 Q3	$241K	Hold	4,155	–	–	0.02%	130
2023 Q2	$266K	Buy	4,155 +5	+0.1%	+$335	0.02%	122
2023 Q1	$288K	Hold	4,150	–	–	0.03%	120
2022 Q4	$299K	Sell	4,150 -12	-0.3%	-$905	0.03%	115
2022 Q3	$295K	Buy	4,162 +12	+0.3%	+$870	0.02%	123
2022 Q2	$319K	Sell	4,150 -2,826	-41%	-$215K	0.03%	102
2022 Q1	$440K	Buy	+6,976	New	+$468K	0.04%	112
2021 Q4	–	Sell	-5,592	Closed	-$328K	–	105
2021 Q3	$330K	Hold	5,592	–	–	0.03%	105
2021 Q2	$373K	Sell	5,592 -1,384	-20%	-$90.2K	0.03%	100
2021 Q1	$440K	Sell	6,976 -58	-0.8%	-$3.61K	0.04%	96
2020 Q4	$436K	Hold	7,034	–	–	0.05%	95
2020 Q3	$424K	Buy	7,034 +7,004	+23,347%	+$422K	0.05%	90
2020 Q2	$444K	Sell	30 -7,529	-100%	-$450K	0.06%	94
2020 Q1	$421K	Buy	7,559 +116	+2%	+$7.09K	0.08%	92
2019 Q4	$477K	Buy	7,443 +525	+8%	+$30.1K	0.07%	89
2019 Q3	$350K	Hold	6,918	–	–	0.06%	94
2019 Q2	$314K	Sell	6,918 -227	-3%	-$10.6K	0.05%	94
2019 Q1	$340K	Buy	7,145 +15	+0.2%	+$747	0.06%	90
2018 Q4	$370K	Hold	7,130	–	–	0.08%	84
2018 Q3	$442K	Hold	7,130	–	–	0.08%	79
2018 Q2	$394K	Sell	7,130 -1,250	-15%	-$67.5K	0.08%	75
2018 Q1	$530K	Hold	8,380	–	–	0.12%	67
2017 Q4	$513K	Buy	8,380 +1,462	+21%	+$91.4K	0.11%	69
2017 Q3	$441K	Hold	6,918	–	–	0.1%	67
2017 Q2	$385K	Buy	+6,918	New	+$376K	0.09%	66
2015 Q4	–	Sell	-3	Closed	–	–	106
2015 Q3	$0	Buy	+3	New	+$190	﹤0.01%	270
2015 Q1	–	Sell	-12	Closed	-$1K	–	303
2014 Q4	$1K	Hold	12	–	–	﹤0.01%	246
2014 Q3	$1K	Buy	+12	New	+$599	﹤0.01%	266

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Baltimore-Washington Financial Advisors's BMY Position: Q4 2023 in Review

Baltimore-Washington Financial Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,155 shares — an estimated $241K sold.

Baltimore-Washington Financial Advisors first reported a position in BMY in Q3 2014 and held it in 28 quarters. The position peaked at $530K in Q1 2018. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Baltimore-Washington Financial Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Baltimore-Washington Financial Advisors sold 4,155 Bristol-Myers Squibb shares in Q4 2023, an estimated $241K.
Baltimore-Washington Financial Advisors first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 28 quarters.
Baltimore-Washington Financial Advisors's Bristol-Myers Squibb position peaked at $530K in Q1 2018.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.